Hot Products

Syringaresinol
Catalog No: CFN92060

(-)-Syringaresinol may be a potential chemotherapeutic agent for the treatment of cancer; it against H/R-induced cardiomyocyte injury and death, the degradation of HIF-1α through activation of FOXO3 is a potential therapeutic strategy for ischemia-related diseases. Syringaresinol induces vasorelaxation by enhancing NO production in endothelial cells via two distinct mechanisms, phosphatidylinositol 3-kinase/Akt- and PLC/Ca(2+)/CaMKKβ-dependent eNOS phosphorylation and Ca(2+)-dependent eNOS dimerization.

Syringaresinol diacetate
Catalog No: CFN98009

Reference standards.

Syringaresinol-di-O-glucoside
Catalog No: CFN90458

Syringaresinol-di-O-glucoside protects the animals from the stress-induced decreases in sex behaviours and in rectal temperature, the stress-induced failure of retrieval of memory, and the stress-induced enlargement of adrenal gland.

Syringetin
Catalog No: CFN70363

Syringetin prevents and treats bone metastasis in patients with lung cancer, it can directly inhibits osteoclastogenesis and reverses lung adenocarcinoma‑mediated osteoclastogenesis. Syringetin can increase BMP-2 synthesis, and subsequently activate SMAD1/5/8 and ERK1/2, and this effect may contribute to its action on the induction of osteoblast maturation and differentiation, followed by an increase of bone mass.

Syringetin-3-O-glucoside
Catalog No: CFN90468

Reference standards.

Syringetin-3-O-rutinoside
Catalog No: CFN91150

Reference standards.

Syringic acid
Catalog No: CFN98884

Syringic acid is a potential antioxidant used in traditional Chinese medicine and is an emerging nutraceutical. It has potential anti-angiogenic, anti-glycating, anti-hyperglycaemic,antimicrobial, fungitoxicity, neuroprotective, antimitogenic, chemo-sensitizing, anti-obesity, anti-inflammatory, anti-steatotic, and memory-enhancing properties. Syringic acid can ameliorate L-arginine methyl ester-induced hypertension by reducing oxidative stress, and can reduce the pancreatic damage induced by alloxan and stimulated β-cell regeneration in diabetic rats. Syringic acid can suppress hepatic fibrosis in chronic liver injury, it inhibits the activation of cultured hepatic stellate cells.

Syringin
Catalog No: CFN99282

Syringin (Eleutheroside B) has neuroprotective, tonic, adaptogenic, antitumour, anti- platelet aggregation, anti-inflammatory, antinociceptive ,and immune-modulating properties. It reduced the expression levels of inducible NO synthase (iNOS) ,COX,TNF-α, Beta Amyloid, and Caspase.

Syringol
Catalog No: CFN92626

Syringol and phenol have modifying effect on NMOR formation in vivo to be similar, the effect of food on NMOR levels in blood is more important than that of the modifiers.

Syringylpropane
Catalog No: CFN92632

Standard reference